These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23617305)

  • 1. Neonatal clinical pharmacology.
    Allegaert K; van de Velde M; van den Anker J
    Paediatr Anaesth; 2014 Jan; 24(1):30-8. PubMed ID: 23617305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond.
    Allegaert K; Mian P; van den Anker JN
    Curr Pharm Des; 2017; 23(38):5769-5778. PubMed ID: 28950819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored tools to improve pharmacotherapy in infants.
    Allegaert K
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1069-78. PubMed ID: 24961300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations.
    Smits A; Kulo A; de Hoon JN; Allegaert K
    Curr Pharm Des; 2012; 18(21):3119-46. PubMed ID: 22564304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of variability in clearance of exogenous compounds in neonates.
    Allegaert K; Van Den Anker JN; Tayman C; De Hoon J
    Verh K Acad Geneeskd Belg; 2009; 71(3):141-64. PubMed ID: 20088252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacology.
    Smits A; Annaert P; Allegaert K
    Int J Pharm; 2013 Aug; 452(1-2):8-13. PubMed ID: 22504091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
    Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
    Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.
    Smits A; van den Anker JN; Allegaert K
    J Pharm Pharmacol; 2017 Apr; 69(4):350-360. PubMed ID: 27364566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of drug metabolism in early neonatal life.
    Allegaert K; van den Anker JN; Naulaers G; de Hoon J
    Curr Clin Pharmacol; 2007 Jan; 2(1):23-9. PubMed ID: 18690852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study.
    de Haan TR; Bijleveld YA; van der Lee JH; Groenendaal F; van den Broek MP; Rademaker CM; van Straaten HL; van Weissenbruch MM; Vermeulen JR; Dijk PH; Dudink J; Rijken M; van Heijst A; Dijkman KP; Gavilanes D; van Kaam AH; Offringa M; Mathôt RA
    BMC Pediatr; 2012 May; 12():45. PubMed ID: 22515424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology in neonates: small size, huge variability.
    Allegaert K; van den Anker JN
    Neonatology; 2014; 105(4):344-9. PubMed ID: 24931327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal pharmacology: extensive interindividual variability despite limited size.
    Tayman C; Rayyan M; Allegaert K
    J Pediatr Pharmacol Ther; 2011 Jul; 16(3):170-84. PubMed ID: 22479159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal medicines research: challenges and opportunities.
    Samardzic J; Turner MA; Bax R; Allegaert K
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1041-52. PubMed ID: 25958820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational paper: do we need neonatal clinical pharmacologists?
    Allegaert K; Langhendries JP; van den Anker JN
    Eur J Pediatr; 2013 Apr; 172(4):429-35. PubMed ID: 22588521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
    Alcorn J; McNamara PJ
    Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal drug therapy: The first frontier of therapeutics for children.
    Allegaert K; van den Anker J
    Clin Pharmacol Ther; 2015 Sep; 98(3):288-97. PubMed ID: 26095519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pharmacology: neonates are not just small adults..
    Allegaert K; Verbesselt R; Naulaers G; van den Anker JN; Rayyan M; Debeer A; de Hoon J
    Acta Clin Belg; 2008; 63(1):16-24. PubMed ID: 18386761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs.
    Van den Anker JN; McCune S; Annaert P; Baer GR; Mulugeta Y; Abdelrahman R; Wu K; Krudys KM; Fisher J; Slikker W; Chen C; Burckart GJ; Allegaert K
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32698409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.